conv.

← The whole story
Business
Novo Nordisk shares plunge 7% as 2030 growth plan disappoints investors

Wall Street questions turnaround strategy amid GLP-1 market loss to Eli Lilly

5 Sep 21 6:55 AM · 5d ago · 7 articles · 1 post · 2 sources · development 5 of 5

ZeroHedge reports that analyst skepticism centers on Novo's ability to execute a turnaround after losing its obesity-market leadership to Eli Lilly & Co. Despite pledging more than five blockbuster drug launches and $23 billion in new sales, the plan failed to address core investor concerns about the company's competitive position.

Wall Street questions turnaround strategy amid GLP-1 market loss to Eli Lilly
Yahoo Finance

Novo Nordisk Danish pharmaceutical companyMike DoustdarMike Doustdar Novo Nordisk Chief Executive OfficerEli Lilly & Co. Rival pharmaceutical company

The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump

Peak 5 pieces in two hours at Sep 21, 5 AM; 16 pieces over 5 days (15 articles · 1 post) Sep 21, 3 AM — 4 pieces · 4 articles — Newswires 4Sep 21, 5 AM — 5 pieces · 4 articles · 1 post — Newswires 4, Mastodon 1Sep 21, 7 AM — 1 piece · 1 article — Newswires 1Sep 21, 9 AM — 2 pieces · 2 articles — Newswires 2Sep 21, 11 AM — 2 pieces · 2 articles — Newswires 2Sep 21, 1 PM — quietSep 21, 3 PM — quietSep 21, 5 PM — quietSep 21, 7 PM — quietSep 21, 9 PM — quietSep 21, 11 PM — quietSep 22, 1 AM — quietSep 22, 3 AM — 1 piece · 1 article — Google News 1Sep 22, 5 AM — 1 piece · 1 article — Google News 1Sep 22, 7 AM — quietSep 22, 9 AM — quietSep 22, 11 AM — quietSep 22, 1 PM — quietSep 22, 3 PM — quietSep 22, 5 PM — quietSep 22, 7 PM — quietSep 22, 9 PM — quietSep 22, 11 PM — quietSep 23, 1 AM — quietSep 23, 3 AM — quietSep 23, 5 AM — quietSep 23, 7 AM — quietSep 23, 9 AM — quietSep 23, 11 AM — quietSep 23, 1 PM — quietSep 23, 3 PM — quietSep 23, 5 PM — quietSep 23, 7 PM — quietSep 23, 9 PM — quietSep 23, 11 PM — quietSep 24, 1 AM — quietSep 24, 3 AM — quietSep 24, 5 AM — quietSep 24, 7 AM — quietSep 24, 9 AM — quietSep 24, 11 AM — quietSep 24, 1 PM — quietSep 24, 3 PM — quietSep 24, 5 PM — quietSep 24, 7 PM — quietSep 24, 9 PM — quietSep 24, 11 PM — quietYesterday, 1 AM — quietYesterday, 3 AM — quietYesterday, 5 AM — quietYesterday, 7 AM — quietYesterday, 9 AM — quietYesterday, 11 AM — quietYesterday, 1 PM — quietYesterday, 3 PM — quietYesterday, 5 PM — quietYesterday, 7 PM — quietYesterday, 9 PM — quietYesterday, 11 PM — quietToday, 1 AM — quietToday, 3 AM — quietToday, 5 AM — quietToday, 7 AM — quietToday, 9 AM — quietToday, 11 AM — quietToday, 1 PM — quiet 1–5
1–5Wall Street questions turnaround strategy…
Sep 22Sep 23Sep 24yesterdaynow · 2:30 PM ET

What was reported 1 claim about this development

  1. 2 outlets Investor Day Bust: Novo Nordisk Plunges As Wall Street's Turnaround Hopes Fade

    first by ZeroHedge, 5d ago · also Yahoo Finance

    1 more headline

All 5 developments of Novo Nordisk shares plunge 7% as 2030 growth plan… →

NewswiresMastodonGoogle News